PSJC Find publication results
- Czyzewski K., Lalowski M.M., Pfeffer A., Barcikowska M. Lipid metabolism parameters in patients with Alzheimer’s disease and their first degree relatives
- Kapaki E., Ilias I., Paraskevas G.P., Theotoka I., Christakopoulou I. Thyroid function in patients with Alzheimer's disease treated with cholinesterase inhibitors
- Religa D., Winblad B. Therapeutic strategies for Alzheimer's disease based on new molecular mechanisms
- Nawrot B. Targeting BACE with small inhibitory nucleic acids ů a future for Alzheimer's disease therapy?
- Kirkitadze M.D., Kowalska A. Molecular mechanisms initiating amyloid beta-fibril formation in Alzheimer's disease
- Juszczyk P., Kolodziejczyk A.S., Grzonka Z. Circular dichroism and aggregation studies of amyloid beta (11-28) fragment and its variants
- Avila J. The influence of aging in one tauopathy: Alzheimer 's disease
- Sobow T., Flirski M., Kloszewska I., Liberski P.P. Plasma levels of alphabeta peptides are altered in amnestic mild cognitive impairment but not in sporadic Alzheimer's disease
- Zarros A.C., Kalopita K.S., Tsakiris S.T. Serotoninergic impairment and aggressive behavior in Alzheimer's disease
- Maruszak A., Gaweda-Walerych K., Soltyszewski I., Zekanowski C. Mitochondrial DNA in pathogenesis of Alzheimer's and Parkinson's diseases
- Dorszewska J., Florczak J., Rozycka A., Kempisty B., Jaroszewska-Kolecka J., Chojnacka K., Trzeciak W.H., Kozubski W. Oxidative DNA damage and level of thiols as related to polymorphisms of MTHFR, MTR, MTHFD1 in Alzheimer's and Parkinson's diseases
- Sobow T., Flirski M., Liberski P., Kloszewska I. Plasma Abeta levels as predictors of response to rivastigmine treatment in Alzheimer's disease
- Zekanowski C., Wojda U. Aneuploidy, chromosomal missegregation, and cell cycle reentry in Alzheimer's disease
- Arif M., Kato T. Increased expression of PAD2 after repeated intracerebroventricular infusions of soluble Abeta25-35 in the Alzheimer's disease model rat brain: effect of memantine